Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
7,173.91
(
0.12%
)
US TECH 100
26,408.40
(
-0.61%
)
Dow Jones
49,310.32
(
0.00%
)
Brent Oil
104.35
(
2.19%
)
Bitcoin
76,595.99
(
-1.00%
)
News Focus
News Focus
Post# of 257454
Next 10
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

DewDiligence

Send PM Follow Ignore
Followers 843
Posts 122891
Boards Moderated 9
Alias Born 09/05/2002

DewDiligence

Member Level

Re: biocqr post# 221228

Wednesday, 04/24/2019 11:32:52 AM

Wednesday, April 24, 2019 11:32:52 AM

Post# of 257454
ARWR earns $25M HBV milestone from JNJ for start of dosing a new phase-1/2 dosing cohort comprised of JNJ-3989 (f/k/a ARO-HBV) and two undisclosed drugs:

https://www.businesswire.com/news/home/20190424005179/en

The ct.gov listing for the trial provides no information on the identities of the undisclosed drugs (https://www.clinicaltrials.gov/ct2/show/NCT03365947 ).

“The efficient-market hypothesis may be
the foremost piece of B.S. ever promulgated
in any area of human knowledge!”

Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

Discover What Traders Are Watching

Explore small cap ideas before they hit the headlines.

Join Today